Michael Kriegler Memorial Lecture Series
About the Series
The Michael Kriegler Memorial Lecture Series was created to perpetuate Dr. Michael Kriegler's spirit and enthusiasm for science by establishing programs that educate and motivate students and scientists — just as Dr. Kriegler did throughout this life. To accomplish this, his wife, Jan Tuttleman, established this lecture series to bring together the San Diego biotech community with the University, the faculty and students to build relationships and to share ideas.
As many of you know, Jan was a member of our community, having graduated in our inaugural 2006 MBA class. Jan was a scientist, investor, philanthropist and entrepreneur. More impressively, as loving mother and wife, as social activist and human rights champion, Jan was a role model and inspiration for many in our Rady community, as well as the much broader community.
Guest Lecturer: Razelle Kurzrock, MD
The Center for Personalized Cancer Therapy: Transforming Cancer Care Now
As part of our 10th anniversary celebration, please join us for the 2013 Michael Kriegler Memorial Lecture featuring inspirational, thought-provoking speaker, Dr. Razelle Kurzrock as she discusses how genomics represents a powerful, disruptive technology that allows us to customize therapy to each individual patient. This approach may render standard strategies for treating cancer obsolete and hence has the potential to transform cancer care.
A panel discussion will follow the presentation. Joining Dr. Kurzrock in discussing Opportunities for and Challenges to Creating a Center for Personalized Cancer Therapy at UC San Diego Moores Cancer Center will be Dr. Scott Lippman, Director of Moores Cancer Center and Senior Associate Dean and Associate Vice Chancellor for Cancer Research and Care; Lada Rasochova, Ph.D., MBA, Director of California Institute for Innovation and Development and Managing Director of the Rady Venture Fund, Rady School of Management; and Prithwish Pal, Ph.D., Technical Marketing Manager at InVivoScribe, Inc. and Rady MBA student. The panel discussion, moderated by Rady alum, Richard Lieber, Ph.D., MBA, Professor of Orthopaedics and Bioengineering at UC San Diego, will include the role the Rady School played in the development of the business plan for the Center for Personalized Cancer Therapy.
Dr. Kurzrock joined UC San Diego Moores Cancer Center in November 2012 as Senior Deputy Center Director for Clinical Science, Director for the Center for Personalized Cancer Therapy and Vice Chief of the Division of Hematology and Oncology. Dr. Kurzrock is best known for creating the largest and best Phase I clinical trials department in the world while at the M.D. Anderson Cancer Center. In FY 2012, this department enrolled about 1,200 patients on 128 therapeutic trials. Dr. Kurzrock's unique approach emphasizes using cutting-edge molecular profiling technologies to match patients with novel targeted therapies reflecting a personalized strategy to optimize cancer treatment that is associated with substantially better outcomes. Dr. Kurzrock has overseen hundreds of clinical trials, mainly using novel targeted molecules, seven of which have gone on to FDA approval. She has been the Principal Investigator on numerous grants and contracts totaling over 50 million dollars and has published almost 500 peer-reviewed articles in a variety of elite medical journals.